© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
September 23, 2015
There are several agents available for patients who experience recurrence, Kumar says, though nearly all of them have the potential to move to an earlier setting.
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
An Angel Among Nurses for Patients With Lung Cancer
Cancer’s Hidden Threat: Post-Diagnosis Anxiety
Expansion of IOA-244 Trial Fully Enrolled for Uveal Melanoma
Phenomenal Awareness and Community Perspective for Lung Cancer Screenings